Li Lanzhen, Sun Lixia, Yu Shuiqing, Ma Chao
Woerma Road Economic Development Zone, Linyi People's Hospital of Economic Development Zone, Linyi, Shandong, China.
Hell J Nucl Med. 2016 Jan-Apr;19(1):49-52. doi: 10.1967/s002449910338. Epub 2016 Mar 1.
A 61 years old woman presented with low grade fever and weight loss for a month. Thyroid function tests showed hyperthyroidism: increased technetium-99m pertechnetate ((99m)Tc O(-)4) and radioiodine ((131)I) uptake and elevated thyroid stimulating hormone receptor antibodies (TSHRAb). She also had high erythrocyte sedimentation rate. Fine-needle aspiration (FNA) biopsies of left thyroid lobe revealed subacute thyroiditis (SAT). Simultaneous occurrence of SAT and Graves' disease (GD) was diagnosed. The patient was in good physical condition after two doses of betamethasone and daily administration of low dose antithyroid drugs.
This case indicated that the measurement of TSHRAb is useful in understanding the clinical course of patients with SAT when thyroid function tests including the (99m)Tc and (131)I uptake are not compatible with the diagnosis. In such cases, GD should be suspected. The mechanism of high (99m)Tc and/or (131)I uptake in patients with simultaneous SAT and GD may be due to the inflammatory process which was detected by FNA in a small part of the left thyroid lobe inducing the stimulating effects of elevated TSHRAb on the undamaged follicular cells.
一名61岁女性出现低热和体重减轻1个月。甲状腺功能检查显示甲状腺功能亢进:高锝酸盐(99mTcO4-)和放射性碘(131I)摄取增加,甲状腺刺激激素受体抗体(TSHRAb)升高。她的红细胞沉降率也很高。左甲状腺叶细针穿刺(FNA)活检显示亚急性甲状腺炎(SAT)。诊断为SAT与格雷夫斯病(GD)同时发生。患者在接受两剂倍他米松和每日服用低剂量抗甲状腺药物后身体状况良好。
该病例表明,当包括99mTc和131I摄取在内的甲状腺功能检查结果与诊断不相符时,检测TSHRAb有助于了解SAT患者的临床病程。在这种情况下,应怀疑GD。SAT和GD同时存在的患者中99mTc和/或131I摄取高的机制可能是由于FNA在左甲状腺叶的一小部分检测到的炎症过程,导致升高的TSHRAb对未受损滤泡细胞产生刺激作用。